Evaluation of Safety and Efficacy of Periprocedural Use of Rivaroxaban and Edoxaban in Catheter Ablation for Atrial Fibrillatio
Not Applicable
- Conditions
- atrial fibrillation
- Registration Number
- JPRN-UMIN000019933
- Lead Sponsor
- Kagoshima University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Not provided
Exclusion Criteria
thrombosis in cardium
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Asymptomatic cerebral microthromboembolism on the day after AF ablation procedure
- Secondary Outcome Measures
Name Time Method hemopericardium in AF ablation